Value Added Tax VAT on Bank Syariah Mandiri BSM Murabahah Transactions continued

PT BANK MANDIRI PERSERO Tbk. AND SUBSIDIARIES NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS 31 DECEMBER 2012 AND 2011 Expressed in millions of Rupiah, unless otherwise stated Appendix 5197 64. SUBSEQUENT EVENTS On 31 January 2013, PT Bank Mandiri Persero Tbk together with PT Taspen Persero, PT Pos Indonesia Persero, and PT Bank Sinar Harapan Bali “BSHB”, a Subsidiary of Bank Mandiri, have signed “Kesepakatan Bersama tentang Kemitraan Strategis Guna Mewujudkan Sinergi Usaha antara PT Bank Mandiri Persero Tbk, dan PT Taspen Persero dan PT Pos Indonesia Persero dan PT Bank Sinar Harapan Bali”. The signing of the agreement is an early phase in which all parties principally agreed to conduct business synergy by investing in BSHB’s shares, as joint venture vehicle, through right issue scheme with Bank Mandiri remain as the majority shareholder. The objective of this initiative is to optimize BSHB in delivering integrated financial service solution in Indonesia, especially to small-medium size segment.

65. NEW ACCOUNTING PRONOUNCEMENTS

Financial Accounting Standard Board of Indonesian Institute of Accountants DSAK-IAI has issued revision on SFAS 38 - Business Combinations Involving Entities Under Common Control, which was effective as at 1 January 2013 and SFAS 60 - Improvements to SFAS 60, which was effective as at 1 January 2013, but early adoption is permitted. Bank Mandiri and Subsidiaries early adopted improvements on SFAS 60 starting since 31 December 2012. DSAK-IAI has also revoked the accounting standard of SFAS 51 PPSAK 10 Quasi Reorganisation, which was effective as at 1 January 2013 Bank Mandiri and Subsidiaries are currently in the process of assessing the adoption of revised SFAS 38.

66. SUPPLEMENTARY INFORMATION

The information presented in Appendix 61 - 69 is a supplementary financial information of PT Bank Mandiri Persero Tbk., the parent company only, which presents the Bank’s investments in Subsidiaries under the cost method. Please refer to Appendix 610 concerning the reclassification to comply with Bapepam and LK regulation No. VIII.G.7.